RESTYLANE/PERLANE/RESTYLANE-L/PERLANE-L INJECTABLE GELS
FDA premarket approval P040024/S071 · decided 2013-10-25
Approval details
- PMA number
- P040024
- Supplement
- S071
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- RESTYLANE/PERLANE/RESTYLANE-L/PERLANE-L INJECTABLE GELS
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2013-09-26
- Decision date
- 2013-10-25
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- IN-HOUSE PREPARED ACIDIC AND BASIC SOLUTIONS, AS WELL AS IN-HOUSE PREPARED WATER FOR INJECTION.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.